ITF Pharma update, page-9

It’s also completely delusional to think that any retail holders and/or posters can be responsible for a share price falling from $2.50 to 12 cents. You have Starpharma and other entities to thank for that.

Three terminated trials with AstraZeneca.
Falling foul of the MHRA in UK.
A long running dispute with the FDA ending in tears.
Fined by the TGA.
A failed/inconclusive Viraleze post-market trial.
Weak and inconclusive internal DEP trial results.
Pathetically weak worldwide sales of marketed products.
No new internal DEP drugs brought to the clinic in almost 5 years.
Dumped from the ASX300.
Institutional shareholders capitulating and dumping.

And what’s to come?
Embarrassing removal from the All Ordinaries next month.
Tax loss selling season.

So yes, please tell me how myself and other posters are driving this share price lower.